noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Climb Bio Inc.

01/09/2025 | Press release | Distributed by Public on 01/09/2025 06:00

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Climb Bio Inc. | News | Health | Company News | Business Announcement | Licensing Agreement | Contracts and Orders | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq PSX | NYSE Chicago

Back